Fail-closed conformal multiresolution error control for conservative three-dimensional dose remapping in synthetic phantoms
Abstract
Conservative dose remapping can be formulated by transporting mass and deposited energy across nonmatching grids, but fixed sampling uses the same number of points per active source cell regardless of case difficulty. We developed conformal multiresolution error control (CoMERC), a fail-closed multilevel quasi-Monte Carlo (QMC) controller for reference-relative target-cell allocation error in a fixed piecewise-constant source model with known deformation. Two randomized nested replicates were evaluated at a probe level of 4 and candidate levels of 8 and 16. Four endpoints were controlled jointly: reference-mass-weighted global, high-gradient, and density-gradient-threshold root-mean-square error, plus eligible-cell maximum absolute error. A split-conformal multiplier was calibrated from 240 synthetic cases, frozen, and evaluated on 400 independent cases from the same generator and 120 cases from a prespecified shifted generator. In the primary set, joint coverage was 394/400 (98.50%; one-sided 95% lower limit, 97.06%), 388/400 cases (97.00%; lower limit, 95.18%) received an output, and 0/388 released outputs exceeded any tolerance (one-sided 95% upper limit, 0.769%). Final actions were level 8 for 190 cases, level 16 for 198, and ABSTAIN for 12. The mean of the case-normalized, policy-implied production-sample ratios was 0.5844, with each case normalized to always running both randomized replicates through level 16; the prespecified 95th-percentile bootstrap upper limit was 0.6194. All seven primary gates passed. In the shifted-generator set, 113/120 cases were released and one released output exceeded a tolerance. CoMERC provided marginal finite-sample error control and lower modeled production-sample work in the locked synthetic population, but not patient-level, registration-level, conditional-on-release, or clinical safety validation.
Related
- Non conservative conformal Killing gravity: coupling the dark sector with curvature and matter
- A Fully Discrete, Mass-Conservative Adaptive Discontinuous Spectral-Element Method for the One-Dimensional Richards Equation in Mixed Form
- Sharp null-energy lower bounds for Page-like entropy excursions in two-dimensional conformal field theory
- Conformal data for the O(2) Wilson-Fisher CFT in (2+1)-dimensional spacetime from exact diagonalization and matrix product states on the fuzzy sphere
- Dosimetric Comparison of Intensity-Modulated Radiotherapy and Four-Field Three-Dimensional Conformal Radiotherapy in the Management of Prostate Cancer: A Retrospective Dual-Centre Analysis
BibTeX
@misc{wang2026failclosed,
title = {{Fail-closed conformal multiresolution error control for conservative three-dimensional dose remapping in synthetic phantoms}},
author = {Yuntao Wang},
howpublished = {arXiv},
year = {2026},
month = oct,
doi = {10.48550/arxiv.2609.13621},
eprint = {2609.13621},
archivePrefix = {arXiv},
url = {https://arxiv.org/abs/2609.13621},
}
RIS
TY - UNPB
TI - Fail-closed conformal multiresolution error control for conservative three-dimensional dose remapping in synthetic phantoms
AU - Yuntao Wang
PY - 2026
DA - 2026/10/02
PB - arXiv
DO - 10.48550/arxiv.2609.13621
UR - https://arxiv.org/abs/2609.13621
AB - Conservative dose remapping can be formulated by transporting mass and deposited energy across nonmatching grids, but fixed sampling uses the same number of points per active source cell regardless of case difficulty. We developed conformal multiresolution error control (CoMERC), a fail-closed multilevel quasi-Monte Carlo (QMC) controller for reference-relative target-cell allocation error in a fixed piecewise-constant source model with known deformation. Two randomized nested replicates were evaluated at a probe level of 4 and candidate levels of 8 and 16. Four endpoints were controlled jointly: reference-mass-weighted global, high-gradient, and density-gradient-threshold root-mean-square error, plus eligible-cell maximum absolute error. A split-conformal multiplier was calibrated from 240 synthetic cases, frozen, and evaluated on 400 independent cases from the same generator and 120 cases from a prespecified shifted generator. In the primary set, joint coverage was 394/400 (98.50%; one-sided 95% lower limit, 97.06%), 388/400 cases (97.00%; lower limit, 95.18%) received an output, and 0/388 released outputs exceeded any tolerance (one-sided 95% upper limit, 0.769%). Final actions were level 8 for 190 cases, level 16 for 198, and ABSTAIN for 12. The mean of the case-normalized, policy-implied production-sample ratios was 0.5844, with each case normalized to always running both randomized replicates through level 16; the prespecified 95th-percentile bootstrap upper limit was 0.6194. All seven primary gates passed. In the shifted-generator set, 113/120 cases were released and one released output exceeded a tolerance. CoMERC provided marginal finite-sample error control and lower modeled production-sample work in the locked synthetic population, but not patient-level, registration-level, conditional-on-release, or clinical safety validation.
ER -